Theravance Biopharma (NASDAQ: TBPH) announced that the Ministry of Health of the Russian Federation has granted marketing authorization for VIBATIV ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE